Staci Gunter, PA
Surgical · Salt Lake City, UTNPI 1003329962
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $890 of the $990 with a category attached, or 89.9%. It is spread thinly across 18 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations.
Across 43 payments — averaging $23.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$205
- Astellas Pharma US Inc$114
- Seagen Inc.$100
- EMD Serono, Inc.$96
- Merck$71
- AbbVie$68
- plus $336 from 12 others
What the payments were for
- Food & beverage$89090%
- Education$10010%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 9 | $205 |
| Astellas Pharma US Inc | 5 | $114 |
| Seagen Inc. | 1 | $100 |
| EMD Serono, Inc. | 5 | $96 |
| Merck | 4 | $71 |
| AbbVie | 3 | $68 |
| Sobi, Inc | 2 | $48 |
| Pfizer | 3 | $48 |
| Array Biopharma Inc | 2 | $44 |
| AstraZeneca | 1 | $27 |
| Sanofi | 1 | $26 |
| Puma Biotechnology, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| Geron Corporation | 1 | $22 |
| Bristol Myers Squibb | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Recordati_rare_diseases_inc. | 1 | $19 |
| Pharming Healthcare, Inc. | 1 | $15 |
How this compares
$990 in reported general payments places this provider in the 70th percentile of 121 surgical providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PiqrayAlpelisib | 12 | $258,632 |
| Anastrozole | 28 | $666 |
| Letrozole | 12 | $283 |
| Ondansetron OdtOndansetron | 13 | $252 |
| Dexamethasone | 16 | $222 |
| Tamoxifen Citrate | 11 | $219 |
| Acyclovir | 14 | $159 |
| Levothyroxine Sodium | 13 | $81 |
Paid to pharmacies, not to this prescriber.
Other surgical in Salt Lake City
- Scott HadfieldSalt Lake City$10K
- Brittany CrossSalt Lake City$6K
- Brittney TaylorSalt Lake City$4K
- Meagan ThomasSalt Lake City$3K
- Jessica WoeppelSalt Lake City$2K
- Danielle ChristensenSalt Lake City$2K
- Jennifer StrumoloSalt Lake City$2K
- Heather GeorgeSalt Lake City$2K
- Cristina BerkholderSalt Lake City$1K
- Meghan CalamelSalt Lake City$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.